“Conversion from Extended-Dose-Release Tacrolimus to Melt-Dose Tacrolimus in High Metabolizer Patients: Is the New Formulation of LPCT the Best Option for High Metabolizer Kidney Transplanted Patients?”. Journal of Renal and Hepatic Disorders 4, no. 1 (May 13, 2020): 18–21. Accessed April 18, 2026. https://jrenhep.com/jrenhep/article/view/68.